1933 Industries Inc Stock Toronto S.E.
Equities
VPR
CA74840V1004
Pharmaceuticals
Sales 2022 | 12.54M 9.18M | Sales 2023 | 18.27M 13.39M | Capitalization | 6.92M 5.07M |
---|---|---|---|---|---|
Net income 2022 | -17M -12.45M | Net income 2023 | -13M -9.52M | EV / Sales 2022 | 2.28 x |
Net Debt 2022 | 17.32M 12.69M | Net Debt 2023 | 16.48M 12.07M | EV / Sales 2023 | 1.28 x |
P/E ratio 2022 |
-0.63
x | P/E ratio 2023 |
-0.51
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 91.27% |
Managers | Title | Age | Since |
---|---|---|---|
Paul Rosen
CEO | Chief Executive Officer | 60 | 20-06-14 |
Ester Vigil
PSD | President | - | - |
Brian Farrell
DFI | Director of Finance/CFO | - | 18-03-14 |
Members of the board | Title | Age | Since |
---|---|---|---|
Donald Skeith
BRD | Director/Board Member | 69 | 15-11-22 |
Brian Farrell
DFI | Director of Finance/CFO | - | 18-03-14 |
Curtis Floyd
BRD | Director/Board Member | - | 23-06-20 |
1st Jan change | Capi. | |
---|---|---|
+26.86% | 4.15B | |
+126.28% | 2.3B | |
+179.37% | 99.91M |